I was diagnosed with MND in July 2023 and my background is in the healthcare industry, having spent 23 years in pharmaceuticals with Sanofi and its predecessor companies and 15 years in the MedTech industry working for GE Healthcare. I retired in 2019 but still do a little consulting work.
Most of my career has been spent working in the neurology domain, launching drugs and diagnostics for conditions such as epilepsy, multiple sclerosis, Alzheimer’s Disease, Parkinson’s Disease and Stroke. When I worked at Aventis, a predecessor of Sanofi, my team was responsible for successfully getting riluzole through its NICE appraisal in 2001. I was also a Board member of the European Brain Council for a number of years.
Given my background in the healthcare industry and the neurological field since my diagnosis, I have become determined to immerse myself in MND, become an expert and make a contribution to help improve care, access to treatments, outcomes and hopefully ultimately find a cure for this cruel, non-discriminatory disease.
I feel honored and privileged to be appointed as a trustee of the Association and I will do all I can to bring the fight with a goal to ultimately defeat MND.